Cargando…
Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
Fetuin-A, a circulating glycoprotein synthesized in the liver, is involved in insulin resistance and type 2 diabetes. However, regulation of fetuin-A synthesis has remained obscure. We previously reported that pioglitazone treatment significantly reduced serum fetuin-A levels in patients with type 2...
Autores principales: | Ochi, Akinobu, Mori, Katsuhito, Emoto, Masanori, Nakatani, Shinya, Morioka, Tomoaki, Motoyama, Koka, Fukumoto, Shinya, Imanishi, Yasuo, Koyama, Hidenori, Ishimura, Eiji, Inaba, Masaaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923806/ https://www.ncbi.nlm.nih.gov/pubmed/24551137 http://dx.doi.org/10.1371/journal.pone.0088704 |
Ejemplares similares
-
Effects of fetuin-A-containing calciprotein particles on posttranslational modifications of fetuin-A in HepG2 cells
por: Uedono, Hideki, et al.
Publicado: (2021) -
The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes
por: Kawarabayashi, Reina, et al.
Publicado: (2017) -
Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes
por: Maruo, Saori, et al.
Publicado: (2018) -
Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes
por: Morioka, Tomoaki, et al.
Publicado: (2014) -
Plasma soluble leptin receptor levels are associated with pancreatic β‐cell dysfunction in patients with type 2 diabetes
por: Morioka, Tomoaki, et al.
Publicado: (2017)